Z-1451-2022 Class II Terminated
FDA device recall Z-1451-2022 was initiated by LumiraDx on Jun 24, 2022 and is designated Class II. Reason for recall: Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA. The recall status is terminated (terminated May 10, 2024). Affected quantity: 99 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 27, 2022
- Initiation Date
- Jun 24, 2022
- Termination Date
- May 10, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99 units
Product description
LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control
Reason for recall
Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.
Distribution pattern
Domestic: AR, CA, FL, MA, MD, NC, NJ, NV, NY, OK, TN, TX, & WI.
Code information
No UDI codes. Catalog No. L017080109002. Lot No. 2002201428 (Exp. 01-Sept-2022).
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1451-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026